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1Introduction
Skeletal muscle undergoes structural adaptations in response 
to changes in functional demand. Prolonged periods of reduced 
muscle activity and mechanical loading, e.g. immobilisation, 
limb-suspension or bed-rest, result in changes in skeletal 
muscle structure and function, bone mineral density (BMD) and 
intermuscular adipose content (1-6). Musculoskeletal trauma 
and sports injuries are often treated with orthopaedic surgery/ 
limb immobilisation, which inevitably leads to periods of 
inactivity and disuse. The prognosis of orthopaedic surgery 
patients is poor especially in the older population with an 
~6 to 17% mortality rate within three years of hip and knee 
joint replacement (7).  Exercise could be beneficial in these 
circumstances, but is not always practical. In addition, there is 
a notable need to identify non-pharmacological interventions 
since polypharmacy in itself is conducive to skeletal tissue loss 
(8).
Eicosapentaenoic acid (EPA) is an n-3 polyunsaturated fatty 
acid with anti-inflammatory properties, which is synthesised 
from ingested alpha-linolenic acid or consumed in fish, or in 
fish oil, such as sardines and cod liver oil. Despite there being 
no established Dietary Reference Intake for n-3 fatty acids, 
adequate intake (AI) is set at 1.6 and 1.1 g/day for men and 
women, respectively (9). There is evidence to suggest that EPA 
may reduce the pro-inflammatory cytokines associated with 
muscle damage-induced inflammation (10). Magee et al. (2008) 
demonstrated in vitro that EPA inhibits the effects of TNF-α 
by reducing its apoptotic effects and enabling myogenesis 
(10). It is unclear whether this supplement would have a 
beneficial effect during immobilisation, where it is generally 
accepted that there is muscle atrophy (11), which is associated 
with decreased protein synthesis [12] but scant evidence for 
increased protein breakdown (13). 
Another non-pharmacological agent that may potentially 
be used against the asthenia and sarcopenia induced through 
immobilisation is vitamin D. Vitamin D is required to 
absorb calcium and phosphorus and plays a crucial role in 
maintaining bone, muscle function, modulation of cell growth, 
neuromuscular and immune functions, and reduction of 
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inflammation. The main source of vitamin D is sunlight, with 
smaller amounts found in certain foods. The Recommended 
Dietary Allowance for vitamin D is 600 IU/day (14). Vitamin 
D supplementation is another way of making sure the 
recommended allowance is achieved. Vitamin D has been 
shown to have direct effects on muscle (15); however, the exact 
mechanisms remain unknown. To date, research has indicated 
an association between genetic variation in the vitamin D 
receptor gene and muscle strength, fat mass and body mass in 
premenopausal women (16). Moreover, vitamin D has been 
reported to impact on both the trans-membranous flows of 
calcium and phosphate in skeletal muscle, and the synthesis 
rate of contractile properties (17). Vitamin D supplementation 
reduced falls by 49% and improved musculoskeletal function in 
frail elderly women with vitamin D deficiency (18). It remains 
to be seen whether vitamin D supplementation in healthy 
persons with no known vitamin D deficiency, would lead to any 
enhancement in muscle structural and contractile properties in 
the presence of immobilisation.
In the present study, an arm immobilisation model 
was chosen as it is relatively less restrictive on daily life 
and causes fewer burdens on participants. The aim was to 
determine the role that the two potential protein-sparing 
modulators (EPA or vitamin D supplementation) may play 
in attenuating atrophy induced through a model that would 
emulate relatively short-term decreased local mobility/activity 
in humans. The differential effect of immobilisation on in 
vivo muscle (thickness), limb composition (lean mass, bone 
parameters and fat mass), and anthropometry (arm girth) was 
systematically monitored. Participants received either omega 
3 (ω-3, a fish oil of a complex of EPA and docosahexaenoic 
acid (DHA)), vitamin D or placebo (Lecithin), hereafter simply 
referred to as EPA, vitamin D or placebo supplementation. 
It was hypothesised that muscle thickness, lean mass and 
arm girth will decrease with limb immobilisation. It was also 
hypothesised that EPA will be the most effective supplement 
at minimising these changes, since it is understood to act on the 
protein synthesis pathways.
Method
Participants
Twenty-four healthy volunteers were recruited from the local 
university campus. All participants provided written informed 
consent before taking part in this study, which was approved 
by the local Ethics Committee of Manchester Metropolitan 
University. Exclusion criteria were any conditions requiring 
the use of medication likely to affect muscle function or 
musculoskeletal health (e.g. statins and oral steroids), and any 
current or history of kidney/liver disease, as those suffering 
with such conditions are more susceptible to the side effects 
of nutritional supplementation. An in-house designed physical 
activity and general health questionnaire, generally used in our 
research laboratories for teaching and research purposes, was 
completed by each participant, to ascertain health, habitual 
physical exercise levels and supplement history prior to the 
study. This questionnaire confirmed all participants were 
recreationally active (defined here as undertaking three hours or 
less of low-to-moderate intensity exercise per week.), free from 
recent (last 6 months) upper limb injury, were not currently 
taking any supplements and had no history of ω-3 or vitamin 
D supplementation within at least the last year. Participants 
were randomly assigned to one of three groups: placebo [PLA: 
n = 8]; EPA [EPA: n = 8]; or vitamin D [Vit-D: n = 8]. For 
anthropometric measurements (height, weight and BMI) in our 
three populations, please see the results section.
Study design
The study used a randomised, double-blind, placebo-
controlled design. All participants attended a familiarisation 
session at least one week prior to the first testing session. All 
testing sessions were completed after an overnight fast. After 
baseline testing, the non-dominant arm was immobilised in a 
sling, with the correct sling wearing procedure demonstrated to 
each participant (Figure 1). Participants were required to wear 
the sling for nine waking hours a day for two continuous weeks, 
removal of the sling was permitted only when necessary (e.g. 
taking a bath/shower, driving, sleeping etc.), minimising any 
movement medio-laterally at the elbow and shoulder, whilst 
requiring participants to not contract the upper musculature 
(including the hands) during the hours of immobilisation. 
Measures of upper arm muscle and subcutaneous fat thickness, 
body composition (lean mass, bone parameters and fat mass), 
and upper and lower arm girth were taken immediately before 
immobilisation (Pre), on removal of the sling (Post), and two 
weeks after re-mobilisation (Post2). 
The placebo group consumed two 1200 mg capsules of 
Soya Lecithin (Holland & Barrett, UK) a day, each daily dose 
typically providing 1464 mg of Phosphatides. The EPA group 
consumed three softgel of High EPA Formula (MorEPA, 
Minami Nutrition, UK), with the daily dose providing 1770 
mg EPA and 390 mg docosahexenoic acid (DHA). The Vit-D 
group consumed one softgel of Vitamin D3 (Now Foods, 
Bloomingdale, U.S.A.), each dose providing 1,000 IU 
of Vitamin D3. The participants consumed the nutritional 
supplements during the two weeks of limb immobilisation. 
Participants were asked to maintain their habitual diet and not 
to perform any unaccustomed strenuous exercise during the 
2 weeks of immobilisation and remobilisation. To monitor 
this, during the immobilisation period participants completed 
a 3-day food diary, a daily activity log (including sling-wear 
hours) and wore a pedometer (Omron Walking style III step 
counter, Omron Healthcare Co., Ltd, Kyoto, Japan) to record 
the number of steps taken each day. The food diaries were 
analysed for macronutrient and micronutrient average intake 
using Microdiet Plus 1.2 (Microdiet, Downlee Systems Ltd, 
UK). All participants recorded their daily sling wear hours. In 
addition, since they were university-based local recruits, they 
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were in full view of at least one member of the research team 
and/or other university staff on campus who had been made 
aware of the study requirement, during their hours on campus. 
Last but not least, participants were questioned during their 
final testing session, to confirm their compliance with the 
protocol.
Muscle and sub-cutaneous adipose thickness measures
All images were recorded after approximately 20 minutes 
seated rest to avoid fluid shifts that might induce interstitial 
and/or intracellular changes (19). Images of the muscle and 
sub-cutaneous adipose tissue of the upper arm were obtained 
using B-mode ultrasonography (AU5, Esaote, Genoa, Italy). 
A 7.5-MHz linear phased-array probe (image depth: 37.1-
92.8mm) was applied in the sagittal plane with minimal 
pressure to the tissue area of interest to avoid image distortion. 
This method has previously been shown to be highly reliable 
for determining muscle and adipose thickness (20-22). Images 
were recorded using Adobe Premiere 6.0 (Adobe Systems, 
USA) and stored for later analysis.
Images were obtained with the participant in an upright, 
seated position with their arm abducted square to the body 
(elbow at 180˚) and resting on the ultrasound machine. In 
the upper arm, the proximal and distal insertions of the 
biceps and triceps brachii were identified by sonography and 
marked on the skin. The midpoint (L50) and a third of the 
distance (L33) from the distal end of the biceps and triceps 
brachii were identified and marked onto the skin. Upper arm 
ultrasonography images were collected in the sagittal plane, 
at both sites on both the biceps and triceps brachii. Muscle 
thickness was measured as the distance from the top of the 
superficial muscle aponeurosis to the bone at both sites along 
the biceps and triceps brachii. Ultrasound assessment of muscle 
tissue content has previously been validated (23-26). Sub-
cutaneous adipose thickness was measured as the distance 
from the bottom of the epidermis to the top of the superficial 
muscle aponeurosis in the biceps and triceps at both sites. Each 
of these distances were measured at three standardised points 
along the width of the probe to obtain average muscle and sub-
cutaneous adipose thicknesses using ImageJ analysis software 
(ImageJ 1.37, Maryland, USA).
Body composition analysis
Body composition was determined using dual-energy X-ray 
absorptiometry (DXA) scanner (Hologic Discovery; Vertec 
Scientific, Reading, Berkshire, UK). Whole body scans were 
performed lasting approximately seven minutes with a dose-
area product (DAP) of 21 cGy*cm2. The appendicular mass 
was isolated from the trunk and head using DXA regional 
computer-generated default lines, with manual adjustment, on 
the anterior view planogram. Measures of BMD, bone mineral 
content (BMC), lean mass, fat mass and fat percentage are 
reported for the immobilised arm only.
Arm girths
Participants assumed a relaxed standing position with arms 
hanging by the sides and palms facing the hips. A measuring 
tape was used to measure upper arm girth at the mid-acromial-
radial and lower arm girth at a fixed point a third of the way 
(from the proximal end) along the length of the radiale-stylion. 
Measurements were repeated three times at each point and 
average girths were calculated.
Measurement reliability
All protocols were assessed for intra as well as inter-day 
reliability. This utilised five participants and entailed carrying 
out measurements three times on day 1, and repeating these 
on day 2, approximately a week later. Within-day coefficient 
of variation (CV) of 0.1 %, 0.1 %, 0.4 %, 0.2 %, 0.3 % and 
0.3 %, and between-day CVs of 0.4 %, 0.2 %, 0.6 %, 0.2 %, 
0.2 % and 0.4 % were yielded for upper arm girth, lower arm 
girth, biceps muscle thickness, triceps muscle thickness, biceps 
subcutaneous adipose thickness and triceps subcutaneous 
adipose thickness, respectively. DXA reliability is reported 
with a CV of 1.0 %.
Statistical analyses
Data were analysed using IBM SPSS v21 (IBM Inc, USA). 
The Shapiro-Wilk test revealed some of the data to be non-
parametric (upper arm muscle and adipose thickness, upper and 
lower arm girths). The effect of immobilisation was examined 
by assessing the changes seen in the PLA group by either 
repeated measures ANOVA (parametric data) or a Friedman 
test (non-parametric data). Parametric change relative to 
baseline values (Pre-to-Post: (Post-Pre)/Pre; and Pre-to-Post2: 
(Post2-Pre)/Pre) were analysed using a repeated measures 
ANOVA, with post-hoc Bonferonni corrected 2-tailed t-tests 
to determine group difference. Non-parametric between 
group effects on change data were analysed using the Kruskal 
Wallis test, with post-hoc Mann-Whitney U tests. All data 
are presented as mean ± standard deviation (SD). Statistical 
significance was set with alpha at ≤ 0.05.
Results
The non-immobilised limb was also monitored throughout 
the immobilisation and supplementation phase. When the 
immobilised limb data was normalised for the non-immobilised 
limb data there was no effect on the outcome measures. Data 
for the non-immobilised limb is therefore not reported in this 
paper.
Homogeneity of sample
There were no significant differences in baseline 
characteristics between the groups (Table. 1). The groups 
similarly did not differ in baseline muscle size  (e.g. bicep 
muscle thickness (L50) - PLA: 28.7 ± 7.1 mm; EPA: 31.1 ± 5.4 
mm; Vit-D: 32.1 ± 6.5 mm), arm girth (PLA: 28.8 ± 3.0 cm; 
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EPA: 28.1 ± 4.0 cm; Vit-D: 29.4 ± 3.2 cm), body composition 
(e.g. lean mass – PLA: 1874.5 ± 595.8 g; EPA: 2361.0 ± 
1116.8 g; Vit-D: 2531.1 ± 832.6 g).
Figure 1
Image demonstrating correct sling wear
Front, side and back view demonstrating sling wear. Sling wear was initially demonstrated 
by the experimenter and on subsequent applications, sling application was self-
administered by each participant. The sling was worn for a minimum of nine waking hours 
a day for 14 days. The elbow joint was positioned at approximately a 90° angle.
Daily physical activity and nutritional intake
No significant differences were observed in calorific intake 
(PLA: males 3134 ± 247 kcal/day and females 1352 ± 506 kcal/
day; EPA: males 1826 ± 780 kcal/day and females 1468 ± 121 
kcal/day; Vit-D: males 2658 ± 679 kcal/day and females 1541 
± 431 kcal/day (p>0.05)) or in habitual physical activity (PLA: 
males 8216 ± 34 steps/day and females 6361 ± 1681 steps/day; 
EPA: males 9648 ± 2934 steps/day and females 5410 ± 2231 
steps/day; Vit-D: males 7795 ± 1050 steps/day and females 
5156 ± 1940 steps/day (p>0.05)) between the groups during 
the course of the immobilisation. This effect was true for the 
EPA, Vit-D and PLA groups. Further diet composition analyses 
revealed no group differences in protein (PLA: 1.1 ± 0.3 g·kg-
1·bw/day; EPA: 1.0 ± 0.3 g·kg-1·bw/day; Vit-D: 1.0 ± 0.6 g·kg-
1·bw/day), carbohydrate (PLA: 3.1 ± 1.5 g·kg-1·bw/day; EPA: 
3.1 ± 1.1 g·kg-1·bw/day; Vit-D: 3.0 ± 1.0 g·kg-1·bw/day), fat 
(PLA: 1.0 ± 0.5 g·kg-1·bw/day; EPA: 1.0 ± 0.5 g·kg-1·bw/day; 
Vit-D: 1.0 ± 0.3 g·kg-1·bw/day), vitamin D (PLA: 1.7 ± 0.7 ug/
day; EPA: 1.6 ± 0.9 ug/day; Vit-D: 2.0 ± 1.6 ug/day) or ω-3 
(PLA: 0.37 ± 0.30 g/day; EPA: 0.36 ± 0.19 g/day; Vit-D: 0.36 
± 0.20 g/day) intake over the immobilisation period between 
the three groups.
Results of the questionnaire revealed that participants 
walked to and from work, university and/or shopping a 
minimum of 30 minutes per day. Examination of the activity 
diaries completed by the participants themselves during 
the immobilisation period, confirmed that the majority of 
participants spent at least half an hour outside each day.
Figure 2
Muscle thickness changes in response to immobilisation and 
supplementation
Percentage change (Mean difference (%) ± SD) in muscle thickness from Pre-to-Post for 
PLA (white bars), EPA (grey bars) and Vit-D (black bars) at the midpoint (L50) and a 
third of the distance (L33) along the length of the biceps and triceps brachii. * Significant 
difference between Pre and Post immobilisation in the PLA group.
Muscle and sub-cutaneous adipose thickness measures
Muscle thickness decreased from Pre to Post at both sites 
(L50 and L33) on the biceps and triceps brachii (p<0.05) 
in the placebo group. The percentage decrease in muscle 
thickness was significantly greater in the triceps brachii (L50 
& L33) than the biceps brachii (L33) (p<0.05) The percentage 
change in muscle thickness at both sites on the biceps and 
triceps brachii did not significantly differ between the groups 
(Figure. 2), though both EPA and Vit-D groups showed a 
non-significant trend towards differing from the PLA group. 
Sub-cutaneous adipose thickness increased significantly post 
immobilisation at L50 of the biceps brachii (p<0.05), with no 
significant change at L33 of the biceps brachii or either site on 
the triceps brachii. The percentage change in adipose thickness 
was not significantly different between groups at both sites on 
the triceps brachii (Figure 3). Percentage change in adipose 
thickness was significantly greater in the PLA than the EPA 
group (p<0.05) and in the Vit-D than the EPA group (p<0.05) 
at L50 and L33 along the biceps brachii.
Body composition
There was a significant decrease in lean mass Post 
immobilisation (p<0.05) but no significant effect of supplement 
group on the percentage change in lean mass (Figure 4). 
Percentage changes in BMC, BMD, fat mass and fat percentage 
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Table 1
Baseline characteristics of all participants
PLA EPA Vit-D
Age (years) 26 ± 6.7 19 ± 1.6 23 ± 5.9
Gender
Males n = 2 n = 4 n = 3
Females n = 6 n = 4 n = 5
Height (cm) 168.7 ± 11.1 169.5 ± 12.0 172.2 ± 8.0
Weight (kg) 69.1 ± 14.2 69.6 ± 23.1 75.2 ± 14.5
BMI 24.1 ± 3.7 24.1 ± 5.1 24.4 ± 5.0
Mean values ± SD for baseline characteristics.
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are displayed in Table 2. No significant change was observed 
in BMD, fat mass or fat percentage. There was a significant 
decrease in BMC from Pre to Post immobilisation in the 
PLA group (p<0.05). There was no significant difference in 
percentage change in BMC, BMD, fat mass or fat percentage 
between the groups Post or Post2 (p>0.05).
Figure 3
Sub-cutaneous adipose thickness changes in response to 
immobilisation and supplementation
Percentage change (Mean difference (%) ± SD) in adipose thickness from Pre-to-Post for 
PLA (white bars), EPA (grey bars) and Vit-D (black bars) at the midpoint (L50) and a 
third of the distance (L33) along the length of the biceps and triceps brachii. * Significant 
difference between Pre and Post immobilisation in the PLA group. † Significant difference 
in % change between groups.
Arm girths
Upper and lower arm girths significantly decreased from Pre 
to Post immobilisation (p<0.05) in the PLA group. There was 
no significant difference in the percentage change in upper or 
lower arm girth between groups (Figure 5).
Figure 4
Lean mass changes in response to immobilisation and 
supplementation
Percentage change (% ± SD) in lean mass from Pre-to-Post and Pre-to-Post2 for PLA 
(white bars), EPA (grey bars) and Vit-D (black bars). * Significant difference between Pre 
and Post immobilisation in the PLA group.
Figure 5
Arm girth changes in response to immobilisation and 
supplementation
Percentage change (% ± SD) in upper (a) and lower (b) arm girth from Pre-to-Post and 
Pre-to-Post2 for PLA (white bars), EPA (grey bars) and Vit-D (black bars). * Significant 
difference between Pre and Post immobilisation in the PLA group.
Discussion
The purpose of this study was to determine the role that 
two potential protein-sparing modulators (EPA or vitamin 
D supplementation) may play in attenuating the deleterious 
physiological changes induced through 2 weeks of 9-waking-
hours-per-day combined arm and shoulder immobilisation. 
We hypothesised that muscle thickness, lean mass and arm 
girth would decrease with limb immobilisation. We found 
evidence to support this, with significant decreases in muscle 
thickness (PLA: -3.2 to -7.8% dependent on anatomical site), 
arm girth (PLA: -0.8 to -1.3% dependent on anatomical site) 
and lean mass (PLA: -3.6% for the immobilised limb). In 
addition, we found a significant increase in sub-cutaneous 
adipose thickness (PLA: 10.3%) and a significant decrease in 
BMC (PLA: -2.3%). It was also hypothesised that EPA would 
be the most effective supplement at minimising the effects 
of immobilisation. In fact, our data show that neither EPA 
nor vitamin D had any significant effect on the responses to 
non-injurious immobilisation, other than on the associated 
accumulation of sub-cutaneous fatty tissue. Nonetheless, a 
few trends towards attenuations in deleterious physiological 
events were observed, in the EPA and Vit-D treated groups. 
*
*
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We discuss the observed trends for the attenuation of some 
parameters. 
A significant change in upper limb muscle thickness is 
evidenced in our ultrasound data, with a significant 
decrease in biceps and triceps brachii muscle thickness with 
immobilisation. The ultrasound data demonstrate a greater 
decrease in triceps brachii muscle (L50 and L33) thickness 
than the biceps brachii (L33) in the PLA group. We had, in 
fact, expected the muscle held in the shortened position (i.e. 
the biceps) to be impacted on more than the muscle held in 
the lengthened position (i.e. the triceps); previous research 
suggests that sarcomeres are added in series when the muscle 
is immobilised in the lengthened position, and sarcomeres are 
lost when the muscle is immobilised in the shortened position 
(27).  In the present study, the elbow was immobilised at 
a 90° angle and, as such, would not have exerted maximal 
lengthening or shortening on the triceps and biceps brachii. 
The EPA and Vit-D supplementation groups demonstrated 
non-significant trends towards smaller decreases in muscle 
thickness in response to immobilisation, suggesting that EPA 
and vitamin D may have some role to play in attenuating 
muscle atrophy associated with disuse. A recent study in an 
animal model demonstrated distinct effects of EPA and DHA 
on protein metabolism (protein synthesis and breakdown) 
with EPA showing a greater ability to result in skeletal muscle 
protein accretion. Further work in humans is required to further 
investigate this and the effects EPA may have in human disuse 
models. Indeed, it is likely that the dose, duration and/or whole 
body measurement of muscle mass that was adopted in these 
animal studies diminished the comparability of animal models 
from our immobilisation model. 
Upper and lower arm girths were shown to decrease 
significantly post immobilisation in the PLA group. We 
used girth as a gross marker of skeletal muscle atrophy, as 
previously used by Matsumura et al (28). A decrease in upper 
arm girth (in the PLA group) suggests a decrease in muscle 
CSA in the upper arm and this supports our ultrasound data 
along with previous findings of a decrease in elbow flexor 
muscle CSA and volume with arm immobilisation (29). The 
decrease in lower arm girth suggests a decrease in forearm 
muscle CSA, and this is in line with finding from Miles et 
al. who reported a decrease in forearm muscle CSA with 
9 days arm casting (30). The significant decrease in limb 
CSA is reflected in our DXA data, with a significant decrease 
in lean mass with immobilisation. The decrease in upper 
arm girth appeared to be attenuated by EPA and vitamin D 
supplementation, with EPA having the greater effect. Similarly, 
in the lower arm, supplementation showed a trend towards 
attenuating the losses in arm girth, this time with vitamin D 
having a slightly greater effect. The EPA group appear to show 
a smaller decrease in lean mass than both other groups.
The ultrasound data revealed no significant change in sub-
cutaneous adipose thickness in the triceps brachii over the 
immobilisation period. Biceps sub-cutaneous adipose thickness, 
however, did significantly increase at the midpoint site in 
the placebo group. Manini et al. (6) reported a significant 
increase in intermuscular adipose tissue and no significant 
change in subcutaneous adipose tissue in response to 4-weeks 
unilateral lower limb suspension. The difference between 
the response of sub-cutaneous adipose tissue to disuse in 
the current study in comparison to Manini et al. may be 
due to the different techniques used to assess the parameter 
(i.e. ultrasound vs. magnetic resonance imaging) and/or the 
differing modes of immobilisation (i.e. arm immobilisation 
vs. unilateral lower limb suspension). It is possible that the 
more stringent immobilisation in their study (throughout daily 
mobile activities, for four weeks), as well as the adiposity site 
(intermuscular), may account for the fact that they observed 
significant increases in adiposity. The present study partially 
agrees with their findings as our data showed a significant 
increase at one region, subcutaneously, along the upper arm 
(i.e. 50% of upper limb length). The EPA group demonstrated 
a significantly smaller increase in biceps sub-cutaneous adipose 
thickness following immobilisation than both the PLA and 
Vit-D groups. This effect may, indeed, be meaningful given 
that diet was monitored and the dietary records demonstrated 
neither time nor between group differences in total calories, 
macronutrients or vitamin D intakes, throughout the study. 
EPA supplementation potential for attenuating increases in sub-
cutaneous adipose thickness in response to disuse. The Vit-D 
group also demonstrated a trend towards an attenuation in the 
increase of sub-cutaneous adipose thickness in comparison to 
Table 2
Changes in immobilised limb composition in response to immobilisation and supplementation
PLA EPA Vit-D
Pre-to-Post Pre-to-Post2 Pre-to-Post Pre-to-Post2 Pre-to-Post Pre-to-Post2
BMC -2.3 ± 1.5 * -1.5 ± 1.1 -0.3 ± 1.0 0.6 ± 1.9 -0.7 ± 1.9 -0.6 ± 0.7
BMD -1.6 ± 2.6 0.4 ± 2.2 -0.5 ± 3.2 -0.3 ± 1.1 0.0 ± 1.5 0.5 ± 2.1
Fat mass 2.0 ± 2.4 -1.4 ± 6.7 3.2 ± 3.2 0.2 ± 1.7 2.0 ± 3.5 1.9 ± 1.8
Fat % 2.1 ± 5.9 0.0 ± 5.2 2.6 ± 5.3 -1.2 ± 4.3 3.4 ± 2.6 0.4 ± 3.6
Percentage change (% ± SD) in immobilised limb composition parameters from Pre-to-Post and Pre-to-Post2 for PLA, EPA and Vit-D. * Significant difference between Pre and Post 
immobilisation in the PLA group.
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the PLA group.
DXA analysis revealed no significant changes in fat mass 
or fat percentage with limb immobilisation. The difference 
in the response of adiposity to disuse in the current study in 
comparison to Manini et al. (6), who reported a significant 
increase in intermuscular adipose tissue, may be due to the 
different techniques used to assess the parameter (i.e. DXA 
vs. magnetic resonance imaging) or the different mode and/
or duration of disuse (i.e. 2 weeks arm immobilisation vs. 4 
weeks unilateral lower limb suspension). Interestingly, the 
increases we reported in sub-cutaneous adipose thickness were 
not matched by our DXA analysis of fat mass or percentage. 
Possible explanations for this include: a) the DXA takes the 
average of the whole limb rather than regional data and hence 
would have averaged-out the regional changes observed with 
the ultrasound; b) it is possible that the tissue density changes 
with immobilisation mean that the DXA may have miss-
qualified muscle and fat after immobilisation (31).
We reported no significant change in BMD (-0.8%/week), 
but a significant decrease in BMC (-1.2%/week) following 
immobilisation. Decreases in bone are often reported in more 
severe and longer periods of disuse. For example, Rittweger et 
al. reported significant decreases in BMC of the tibia (-0.1 to 
-0.5/week) and radius (-0.03 to -0.05%/week) in response to 90 
days bed rest (5). Marchetti et al. found significant decreases 
in BMD (-1.0 to 2.3%/week) in response to 6 weeks arm 
immobilisation, however, the participants had also undergone 
surgery, which could contribute to greater decreases in BMD 
(32). Values for BMC and BMD changes with immobilisation 
showed a trend towards attenuation of changes with EPA and 
vitamin D supplementation. Previous research indicates that 
BMD is affected by changes in body weight and composition 
(33), therefore our observed changes in muscle and sub-
cutaneous adipose thickness may have influenced our BMD 
values. The value of BMD can also be limited by the inherent 
limitations of using a two-dimensional x-ray projection to 
estimate bone area and geometrical changes.  The use of 
peripheral quantitative tomography (pQCT) may have been 
more advantageous to examine these specific changes.
A recent study in our own laboratory, found that a lower 
dose of EPA and DHA than that used in the current study, was 
not sufficient to decrease inflammation (34). We therefore 
chose to increase the EPA and DHA of our ω-3 supplement 
in the current study, in line with previous levels used in the 
literature (35-37). The vitamin D dose of 1000 IU is equal to 25 
ug. Public Health England suggest that adults at risk of vitamin 
D deficiency should take a daily supplement containing 10 
ug of vitamin D (38). Our selected dose is much higher than 
this and as such should be sufficient in the healthy population 
used in the current study. The formula of each supplement was 
chosen so that the dose provided would be able to be bought 
over the counter and be taken without prescription. The lack 
of the effectiveness of vitamin D and EPA in the current study 
may be due to the dosage of the supplements used and therefore 
this needs to be altered, potentially increased, in future studies.
The NHS consensus on vitamin D states that if people 
achieve a sufficient supply of vitamin D in the summer, most 
should keep levels greater than the deficiency threshold of 
25nmol/l in winter even without supplements (39). In the 
current study, participants reported that they typical spent at 
least 30 minutes outdoors every day of the week and as such 
would reach the necessary sunlight exposure for adequate 
vitamin D levels.  Research has shown that light of even 
relatively low intensity (~180 lux) significantly phase-shifts 
the human circadian rhythm [40]. We therefore suggest that the 
current population are unlikely to be vitamin D deficient. The 
‘healthy, presumably non-deficient’ status of the participants 
may have been another reason for the lack of effectiveness of 
the supplementation in the current study. In a recent study, it 
was reported that in an elderly population, most participants 
were unable to meet the recommended daily omega-3 (ω-3) 
intake without the use of fish oil supplements (41). Future 
studies need to recruit those lacking in physiological reserve 
and those more at risk of malnutrition/deficiencies e.g. older 
and/or injured persons. Future studies also need to assess 
endocrine markers, including serum EPA & DHA, 25(OH)
D3 levels (biomarker for vitamin D status) and parathyroid 
hormone (PTH) to observe the effects of supplementation.
Blinding of ω-3 supplementation is sometimes an issue 
in studies due to the fact that it often repeats on participants. 
On completion of the study, participants were asked whether 
they were able to identify what supplement they believed 
they were taking. None of the participants correctly guessed 
the supplement they were taking and in fact, two participants 
receiving the placebo supplement believed they were taking an 
ω-3 supplement.
Conclusion
In accordance with previous research, we demonstrated a 
decrease in muscle thickness, arm girth and lean mass with 
short-term upper limb immobilisation. We also observed 
a significant decrease in BMC, with no observed effect of 
immobilisation on fat mass or BMD. At the current dosage, 
neither vitamin D nor EPA supplementation impacted on these 
parameters at a statistically significant level. Interestingly 
nonetheless, we have observed that in the case of sub-cutaneous 
adiposity on the biceps brachii, there is a protective effect of 
EPA supplementation against limb immobilisation. We propose 
that the model used in the current study could have relevance 
to a sporting population in which short-term immobilisation 
may be prescribed (e.g. treatment for minor injury) or in 
clinical populations (e.g. injury/surgery induced short-term 
immobilisation/bed-rest). A short-term model such as this 
is relatively less invasive and inconvenient for participants 
and therefore provides a model to be used to assess other 
supplements and treatments in future studies.
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